Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus.

Zisser H, Jovanovic L, Markova K, Petrucci R, Boss A, Richardson P, Mann A.

Diabetes Technol Ther. 2012 Nov;14(11):997-1001. doi: 10.1089/dia.2012.0101. Epub 2012 Oct 9.

PMID:
23046397
[PubMed - indexed for MEDLINE]
2.
3.

Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.

Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ.

Clin Ther. 2004 Sep;26(9):1492-7.

PMID:
15531011
[PubMed - indexed for MEDLINE]
4.

Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.

Matsuura K, Mori Y, Nakamura A, Yokoyama J, Utsunomiya K.

Diabetes Technol Ther. 2012 May;14(5):423-9. doi: 10.1089/dia.2011.0188. Epub 2012 Feb 8.

PMID:
22316114
[PubMed - indexed for MEDLINE]
5.

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

Malone JK, Kerr LF, Campaigne BN, Sachson RA, Holcombe JH; Lispro Mixture-Glargine Study Group.

Clin Ther. 2004 Dec;26(12):2034-44. Erratum in: Clin Ther. 2005 Jul;27(7):1112.

PMID:
15823767
[PubMed - indexed for MEDLINE]
6.

Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.

Hompesch M, Muchmore DB, Morrow L, Ludington E, Vaughn DE.

Diabetes Technol Ther. 2012 Mar;14(3):218-24. doi: 10.1089/dia.2011.0117. Epub 2011 Dec 2.

PMID:
22136324
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.

Rosenstock J, Bergenstal R, Defronzo RA, Hirsch IB, Klonoff D, Boss AH, Kramer D, Petrucci R, Yu W, Levy B; 0008 Study Group.

Diabetes Care. 2008 Nov;31(11):2177-82. doi: 10.2337/dc08-0315. Epub 2008 Aug 4.

PMID:
18678610
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.

Smart CE, Ross K, Edge JA, Collins CE, Colyvas K, King BR.

Diabet Med. 2009 Mar;26(3):279-85. doi: 10.1111/j.1464-5491.2009.02669.x.

PMID:
19317823
[PubMed - indexed for MEDLINE]
9.

Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitus.

Roach P, Arora V, Campaigne BN, Mattoo V, Rangwala S; India Mix25/Mix50 Study Group.

Diabetes Obes Metab. 2003 Sep;5(5):311-6.

PMID:
12940868
[PubMed - indexed for MEDLINE]
10.

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

Clin Ther. 2000 Feb;22(2):222-30.

PMID:
10743981
[PubMed - indexed for MEDLINE]
11.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
[PubMed - indexed for MEDLINE]
12.

Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.

Kuroda A, Yasuda T, Takahara M, Sakamoto F, Kasami R, Miyashita K, Yoshida S, Kondo E, Aihara K, Endo I, Matsuoka TA, Kaneto H, Matsumoto T, Shimomura I, Matsuhisa M.

Diabetes Technol Ther. 2012 Nov;14(11):1077-80. doi: 10.1089/dia.2012.0109.

PMID:
23101953
[PubMed - indexed for MEDLINE]
13.
14.
15.

Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.

McVey E, Hirsch L, Sutter DE, Kapitza C, Dellweg S, Clair J, Rebrin K, Judge K, Pettis RJ.

J Diabetes Sci Technol. 2012 Jul 1;6(4):743-54.

PMID:
22920798
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.

PMID:
20144416
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes.

Hollander PA, Cefalu WT, Mitnick M, Lawrence D, Rosenstock J.

Diabetes Technol Ther. 2010 Mar;12(3):185-91. doi: 10.1089/dia.2009.0114.

PMID:
20151768
[PubMed - indexed for MEDLINE]
18.

Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.

Clin Ther. 2009 May;31(5):980-7. doi: 10.1016/j.clinthera.2009.05.010.

PMID:
19539098
[PubMed - indexed for MEDLINE]
19.

The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.

Galic E, Vrtovec M, Bozikov V, Schwarzenhofer M, Milicevic Z.

Med Sci Monit. 2005 Dec;11(12):PI87-92. Epub 2005 Nov 24.

PMID:
16319804
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk